<code id='66D8817346'></code><style id='66D8817346'></style>
    • <acronym id='66D8817346'></acronym>
      <center id='66D8817346'><center id='66D8817346'><tfoot id='66D8817346'></tfoot></center><abbr id='66D8817346'><dir id='66D8817346'><tfoot id='66D8817346'></tfoot><noframes id='66D8817346'>

    • <optgroup id='66D8817346'><strike id='66D8817346'><sup id='66D8817346'></sup></strike><code id='66D8817346'></code></optgroup>
        1. <b id='66D8817346'><label id='66D8817346'><select id='66D8817346'><dt id='66D8817346'><span id='66D8817346'></span></dt></select></label></b><u id='66D8817346'></u>
          <i id='66D8817346'><strike id='66D8817346'><tt id='66D8817346'><pre id='66D8817346'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:5
          WuXi AppTec company logo on a phone screen against a backgroud showing stock graph — coverage from STAT
          Adobe

          WASHINGTON — The federal government increasingly is scrutinizing Chinese businesses and their interactions with American companies, including in the biotech sector. Chinese biotechnology companies, the thinking goes, could threaten national security by giving the Chinese government access to the genetic and health information of Americans.

          Just Wednesday, President Biden issued an executive order aimed at keeping sensitive data, including Americans’ genetic information, out of the hands of adversaries.

          advertisement

          But American biotech companies worry they could become collateral damage if the government sloppily targets sanctions. They’re pushing back against legislation that would bar biotech companies from working with some Chinese companies, especially as the government takes aim at WuXi, a Chinese company considered a crucial partner for discovering, testing, and making medicines that has worked with such brands as Pfizer, AstraZeneca, and GSK.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.
          Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

          AdobeDiagnosticerrors—thatis,overlookingadisease,ordiagnosingiterroneouslyorlate—areaknownoccurrence

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          Dispute over threat of extinction posed by artificial intelligence looms over surging industry

          5:08Advancedhumanoidrobot'Sophia'ispicturedatAIforGoodGlobalSummit,inGeneva,Switzerland,July6,2023.P